Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Safety Report: VistaPharm Sucralfate Oral Suspension 1g/10mL - recalled due to Potential Bacillus cereus, USA

8 months ago source fda.gov

Recall notice

United States

VistaPharm LLC is voluntarily recalling one (1) lot of Sucralfate Oral Suspension, 1g/10mL, to the consumer level, due to Bacillus cereus contamination in the product. This product was distributed Nationwide to three (3) distributors by wholesale. To date, VistaPharm LLC has not received any reports of adverse events related to this recall.

Risk Statement:  In the population most at risk, the immunocompromised population, there is a reasonable probability that microbial contamination of the oral suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.

The product is Sucralfate Oral Suspension 1g/10m, used as an antiulcer therapeutic, and is packaged in a 16oz (414mL) PET Bottle with NDC 66689-305-16. The lot is 810300 with an expiration Date of October 31, 2023. The product can be identified with its product name Sucralfate Oral Suspension 1g per 10mL, with the product Lot No and expiration date, at the bottom right side of the label.

A Contractor, Inmar, will perform this recall process, which is notifying its distributors by recall packet delivered by FEDEX Next Day Delivery and will receive an email notification as well. In addition, Inmar is arranging for the return of all recalled products. Distributors that have any bottles remaining from Sucralfate Oral Suspension Lot 810300, which is being recalled, should return to Inmar via instructions provided.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Potential contamination with Bacillus cereus
Brand name: VistaPharm
Product recalled: Sucralfate Oral Suspension 1g/10mL
Reason of the recall: Potential contamination with Bacillus cereus
FDA Recall date: September 22, 2023

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vistapharm-llc-issues-voluntary-nationwide-recall-sucralfate-oral-suspension-1g10ml-due-microbial

#drugs #us #bacilluscereus

Recent Interesting Reports

J

SlimXCel Keto+ACV Gummies, Las Vegas, NV, USA

3 weeks ago reported by user-jxhxb147 details

I live in Canada and yesterday I received 6 containers I did not order called SlimXCel Keto+ACV Gummies. I saw the charge on my credit card about 2 weeks ago. I cannot find how to stop the charge or get a refund. The parcel label says it… See more

#unorderedpackage #subscriptionscam #ketogummiesscam #delivery #lasvegas #nevada #us

B

Unordered Package from Emily Hunt, Edison, NJ, USA

3 weeks ago reported by user-bfhvm369 details

I see other posts about receiving weird deliveries from Emily Hunt, 125 Jackson Ave, Edison, NJ. 08837. I don't know how this person got my address but I just received in the mail today (sent by USPS Ground Advantage) an envelope from same person with nothing but… See more

#unorderedpackage #delivery #uspostalservice #edison #newjersey #us

Hospira, Inc., a Pfizer company (“Pfizer”), is voluntarily recalling the lots listed in the table below of Buprenorphine Hydrochloride Injection CarpujectTM Units and Labetalol Hydrochloride Injection, USP CarpujectTM Units to the User level. The recall was initiated due to the potential for incomplete crimp seals; one customer… See more

#pfizer #recall #drugs #us

Last 30 days